Anti-Mycobacterium tuberculosis Ag85B 抗体 (ab43019)

ab43019 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab43019 は 5 報の論文で使用されています。

  • Torabi-Parizi P  et al. Pathogen-related differences in the abundance of presented antigen are reflected in CD4+ T cell dynamic behavior and effector function in the lung. J Immunol 192:1651-60 (2014). PubMed: 24431231
  • Rath P  et al. Genetic regulation of vesiculogenesis and immunomodulation in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 110:E4790-7 (2013). WB . PubMed: 24248369
  • Wang C  et al. Immunogenicity and Protective Efficacy of a Novel Recombinant BCG Strain Overexpressing Antigens Ag85A and Ag85B. Clin Dev Immunol 2012:563838 (2012). WB . PubMed: 22570667
  • You Q  et al. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis. Scand J Immunol 75:77-84 (2012). WB . PubMed: 21916923
  • Shi C  et al. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein. Vaccine 28:5237-44 (2010). PubMed: 20538090

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"